Literature DB >> 23535202

PKA: lessons learned after twenty years.

Susan S Taylor1, Ping Zhang, Jon M Steichen, Malik M Keshwani, Alexandr P Kornev.   

Abstract

The first protein kinase structure, solved in 1991, revealed the fold that is shared by all members of the eukaryotic protein kinase superfamily and showed how the conserved sequence motifs cluster mostly around the active site. This structure of the PKA catalytic (C) subunit showed also how a single phosphate integrated the entire molecule. Since then the EPKs have become a major drug target, second only to the G-protein coupled receptors. Although PKA provided a mechanistic understanding of catalysis that continues to serve as a prototype for the family, by comparing many active and inactive kinases we subsequently discovered a hydrophobic spine architecture that is a characteristic feature of all active kinases. The ways in which the regulatory spine is dynamically assembled is the defining feature of each protein kinase. Protein kinases have thus evolved to be molecular switches, like the G-proteins, and unlike metabolic enzymes which have evolved to be efficient catalysis. PKA also shows how the dynamic tails surround the core and serve as essential regulatory elements. The phosphorylation sites in PKA, introduced both co- and post-translationally, are very stable. The resulting C-subunit is then packaged as an inhibited holoenzyme with cAMP-binding regulatory (R) subunits so that PKA activity is regulated exclusively by cAMP, not by the dynamic turnover of an activation loop phosphate. We could not understand activation and inhibition without seeing structures of R:C complexes; however, to appreciate the structural uniqueness of each R2:C2 holoenzyme required solving structures of tetrameric holoenzymes. It is these tetrameric holoenzymes that are localized to discrete sites in the cell, typically by A Kinase Anchoring Proteins where they create discrete foci for PKA signaling. Understanding these dynamic macromolecular complexes is the challenge that we now face. This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535202      PMCID: PMC3763834          DOI: 10.1016/j.bbapap.2013.03.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  43 in total

1.  An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

Authors:  Christopher K Means; Birgitte Lygren; Lorene K Langeberg; Ankur Jain; Rose E Dixon; Amanda L Vega; Matthew G Gold; Susanna Petrosyan; Susan S Taylor; Anne N Murphy; Taekjip Ha; Luis F Santana; Kjetil Tasken; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

Review 2.  Protein kinases: evolution of dynamic regulatory proteins.

Authors:  Susan S Taylor; Alexandr P Kornev
Journal:  Trends Biochem Sci       Date:  2010-10-23       Impact factor: 13.807

3.  Distal recognition sites in substrates are required for efficient phosphorylation by the cAMP-dependent protein kinase.

Authors:  Stephen J Deminoff; Vidhya Ramachandran; Paul K Herman
Journal:  Genetics       Date:  2009-04-13       Impact factor: 4.562

Review 4.  Allostery and binding cooperativity of the catalytic subunit of protein kinase A by NMR spectroscopy and molecular dynamics simulations.

Authors:  Larry R Masterson; Alessandro Cembran; Lei Shi; Gianluigi Veglia
Journal:  Adv Protein Chem Struct Biol       Date:  2012       Impact factor: 3.507

5.  A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase.

Authors:  Francis S Kinderman; Choel Kim; Sventja von Daake; Yuliang Ma; Bao Q Pham; Glen Spraggon; Nguyen-Huu Xuong; Patricia A Jennings; Susan S Taylor
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

6.  A chimeric mechanism for polyvalent trans-phosphorylation of PKA by PDK1.

Authors:  Robert A Romano; Natarajan Kannan; Alexandr P Kornev; Craig J Allison; Susan S Taylor
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

Review 7.  Serine/threonine phosphatases: mechanism through structure.

Authors:  Yigong Shi
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

8.  Physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase: effect of MgATP on protein-protein interactions.

Authors:  F W Herberg; S S Taylor
Journal:  Biochemistry       Date:  1993-12-21       Impact factor: 3.162

9.  A small novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane.

Authors:  Pepijn P Burgers; Yuliang Ma; Luigi Margarucci; Mason Mackey; Marcel A G van der Heyden; Mark Ellisman; Arjen Scholten; Susan S Taylor; Albert J R Heck
Journal:  J Biol Chem       Date:  2012-10-31       Impact factor: 5.157

10.  Mg X ATP2-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit.

Authors:  S Whitehouse; D A Walsh
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

View more
  115 in total

1.  STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1.

Authors:  Izabela Durzynska; Xiang Xu; Guillaume Adelmant; Scott B Ficarro; Jarrod A Marto; Piotrek Sliz; Sacha Uljon; Stephen C Blacklow
Journal:  Structure       Date:  2017-01-12       Impact factor: 5.006

2.  Channeling of cAMP in PDE-PKA Complexes Promotes Signal Adaptation.

Authors:  Nikhil Kumar Tulsian; Srinath Krishnamurthy; Ganesh Srinivasan Anand
Journal:  Biophys J       Date:  2017-06-20       Impact factor: 4.033

3.  Lithocholic bile acid accumulated in yeast mitochondria orchestrates a development of an anti-aging cellular pattern by causing age-related changes in cellular proteome.

Authors:  Adam Beach; Vincent R Richard; Simon Bourque; Tatiana Boukh-Viner; Pavlo Kyryakov; Alejandra Gomez-Perez; Anthony Arlia-Ciommo; Rachel Feldman; Anna Leonov; Amanda Piano; Veronika Svistkova; Vladimir I Titorenko
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Anxiety-like behavior and other consequences of early life stress in mice with increased protein kinase A activity.

Authors:  Maddalena Ugolini; Margaret F Keil; Enrica Paradiso; John Wu; Constantine A Stratakis
Journal:  Behav Brain Res       Date:  2018-04-03       Impact factor: 3.332

5.  Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.

Authors:  Tsan-Wen Lu; Jian Wu; Phillip C Aoto; Jui-Hung Weng; Lalima G Ahuja; Nicholas Sun; Cecilia Y Cheng; Ping Zhang; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-30       Impact factor: 11.205

Review 6.  Adenylyl cyclases in the digestive system.

Authors:  Maria Eugenia Sabbatini; Fred Gorelick; Shannon Glaser
Journal:  Cell Signal       Date:  2014-02-09       Impact factor: 4.315

7.  PKA-type I selective constrained peptide disruptors of AKAP complexes.

Authors:  Yuxiao Wang; Tienhuei G Ho; Eugen Franz; Jennifer S Hermann; F Donelson Smith; Heidi Hehnly; Jessica L Esseltine; Laura E Hanold; Mandi M Murph; Daniela Bertinetti; John D Scott; Friedrich W Herberg; Eileen J Kennedy
Journal:  ACS Chem Biol       Date:  2015-03-25       Impact factor: 5.100

8.  Protein kinase A in the neutron beam: Insights for catalysis from directly observing protons.

Authors:  Oksana Gerlits; Kevin L Weiss; Matthew P Blakeley; Gianluigi Veglia; Susan S Taylor; Andrey Kovalevsky
Journal:  Methods Enzymol       Date:  2020-01-17       Impact factor: 1.600

Review 9.  Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.

Authors:  Morgan K Penny; Isabella Finco; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2016-12-08       Impact factor: 4.102

10.  Defining A-Kinase Anchoring Protein (AKAP) Specificity for the Protein Kinase A Subunit RI (PKA-RI).

Authors:  Karolin Autenrieth; N George Bendzunas; Daniela Bertinetti; Friedrich W Herberg; Eileen J Kennedy
Journal:  Chembiochem       Date:  2015-12-17       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.